Biomerica Secures Vietnam Approval for EZ Detect, Opens 680M-Person Market
Vietnam’s Hanoi Department of Health approved Biomerica’s FDA-cleared EZ Detect at-home colorectal screening test for nationwide distribution through pharmacies, hospitals and online channels. This milestone entry targets Southeast Asia’s 680 million people and Vietnam’s 16,835 yearly colorectal cancer cases with only a 45% five-year survival rate.
1. Approval Details and Distribution
The Hanoi Department of Health granted approval for EZ Detect, allowing Biomerica to distribute its two-minute at-home colorectal screening test across Vietnam via pharmacies, hospitals, physician offices and online channels. Biomerica has partnered with a major local healthcare distributor to manage logistics and sales nationwide.
2. Market Opportunity in Vietnam
Vietnam records 16,835 new colorectal cancer cases annually, making it the country’s fourth most common cancer, with a five-year survival rate of just 45%. Southeast Asia’s population of 680 million and rapidly growing healthcare spending present significant upside for at-home diagnostics.
3. EZ Detect Advantages and Compliance
EZ Detect identifies occult blood in stool without requiring handling or lab processing, providing results in two minutes with a simple flushable pad. Clinical validation showed a 92% patient preference over conventional tests, addressing barriers that limit real-world screening completion.
4. Regional Expansion Strategy
This approval serves as a template for Biomerica’s further rollout across Southeast Asia, targeting markets with similar unmet screening needs. The company aims to leverage its distribution partner’s network to accelerate adoption and drive revenue growth in high-potential developing markets.